Agios Pharmaceuticals Ownership 2024 | Who Owns Agios Pharmaceuticals Now?
Institutional Ownership
96.29%
Insider Ownership
1.55%
Retail Ownership
2.16%
Institutional Holders
208.00
Agios Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 9.95% | 1.15% | 5,654,502 | 63,900 | 1.14% | 243,822,126 | Jun 30, 2024 |
| VANGUARD GROUP INC | 9.68% | 0.00% | 5,496,737 | -75,284 | -1.35% | 237,019,300 | Jun 30, 2024 |
| BLACKROCK INC. | 8.55% | 0.00% | 4,859,002 | 200,907 | 4.31% | 209,520,165 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 6.83% | 2.72% | 3,879,548 | -126,452 | -3.16% | 167,286,110 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.89% | 0.01% | 2,777,259 | 764,266 | 37.97% | 119,756,000 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 3.87% | 0.02% | 2,196,085 | -382,473 | -14.83% | 94,697,055 | Jun 30, 2024 |
| STATE STREET CORP | 3.72% | 0.00% | 2,114,949 | -1,023,248 | -32.61% | 91,196,601,000 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 3.66% | 1.13% | 2,079,151 | -884,849 | -29.85% | 89,652,991 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 3.13% | 0.01% | 1,776,145 | -696,545 | -28.17% | 76,587,373 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 3.05% | 0.09% | 1,729,729 | -229,928 | -11.73% | 74,586,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.38% | 0.01% | 1,351,430 | 68,515 | 5.34% | 58,285,087 | Jun 30, 2024 |
| BVF INC/IL | 2.10% | 1.44% | 1,190,107 | 1,190,107 | 100.00% | 51,317,414 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 2.00% | 0.07% | 1,133,735 | 855,739 | 307.82% | 48,886,654 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.84% | 1.36% | 1,044,261 | -720,244 | -40.82% | 45,028,534 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.79% | 0.52% | 1,019,357 | -499,806 | -32.90% | 43,954,674 | Jun 30, 2024 |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 1.60% | 0.10% | 911,175 | -197,438 | -17.81% | 39,290,000 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.54% | 1.76% | 871,974 | 348,808 | 66.67% | 37,599,519 | Jun 30, 2024 |
| FISHER ASSET MANAGEMENT, LLC | 1.25% | 0.01% | 709,912 | 2,570 | 0.36% | 30,611,404 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.19% | 0.03% | 678,234 | 316,100 | 87.29% | 29,245,450 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 1.17% | 0.01% | 662,236 | -5,061 | -0.76% | 28,555,616 | Jun 30, 2024 |
Agios Pharmaceuticals's largest institutional shareholder is FARALLON CAPITAL MANAGEMENT LLC, holding 9.95% of the company's total share outstanding, currently valued at $243.82M. The top 10 institutional shareholders own together 57.33% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CALIGAN PARTNERS LP | 0.91% | 5.19% | 514,711 | 30,000 | 6.19% | 22,194,338 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 0.14% | 2.86% | 78,700 | 23,438 | 42.41% | 3,393,544 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 6.83% | 2.72% | 3,879,548 | -126,452 | -3.16% | 167,286,110 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.79% | 2.58% | 446,416 | 446,416 | 100.00% | 19,249,458 | Jun 30, 2024 |
| EAGLE HEALTH INVESTMENTS LP | 0.58% | 2.50% | 330,830 | - | - | 14,265,390 | Jun 30, 2024 |
| SECTOR GAMMA AS | 0.21% | 1.96% | 121,844 | -42,534 | -25.88% | 5,253,913 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.54% | 1.76% | 871,974 | 348,808 | 66.67% | 37,599,519 | Jun 30, 2024 |
| BVF INC/IL | 2.10% | 1.44% | 1,190,107 | 1,190,107 | 100.00% | 51,317,414 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.84% | 1.36% | 1,044,261 | -720,244 | -40.82% | 45,028,534 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 9.95% | 1.15% | 5,654,502 | 63,900 | 1.14% | 243,822,126 | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 3.66% | 1.13% | 2,079,151 | -884,849 | -29.85% | 89,652,991 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 0.44% | 0.67% | 249,311 | 249,311 | 100.00% | 10,750,290 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.79% | 0.52% | 1,019,357 | -499,806 | -32.90% | 43,954,674 | Jun 30, 2024 |
| EAM INVESTORS, LLC | 0.13% | 0.52% | 74,142 | 74,142 | 100.00% | 3,197,003 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.13% | 0.31% | 75,280 | -18,124 | -19.40% | 3,246,074 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 0.24% | 0.24% | 136,838 | 136,838 | 100.00% | 5,900,455 | Jun 30, 2024 |
| GW&K INVESTMENT MANAGEMENT, LLC | 1.05% | 0.23% | 595,066 | -54,319 | -8.36% | 25,659,000 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.39% | 0.23% | 223,979 | -45,000 | -16.73% | 9,657,974 | Jun 30, 2024 |
| SEVEN EIGHT CAPITAL, LP | 0.07% | 0.18% | 39,262 | 39,262 | 100.00% | 1,692,977 | Jun 30, 2024 |
| PENNANT INVESTORS, LP | 0.03% | 0.17% | 15,100 | - | - | 651,112 | Jun 30, 2024 |
The largest Agios Pharmaceuticals shareholder by % of total assets is CALIGAN PARTNERS LP. The company owns 514.71K shares of Agios Pharmaceuticals (AGIO), representing 5.19% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | 2.10% | 1.44% | 1,190,107 | 1,190,107 | 100.00% | 51,317,414 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 2.00% | 0.07% | 1,133,735 | 855,739 | 307.82% | 48,886,654 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.89% | 0.01% | 2,777,259 | 764,266 | 37.97% | 119,756,000 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.82% | 0.13% | 464,121 | 464,121 | 100.00% | 20,012,896 | Jun 30, 2024 |
| LOOMIS SAYLES & CO L P | 0.79% | 0.03% | 448,863 | 448,863 | 100.00% | 19,355,000 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.79% | 2.58% | 446,416 | 446,416 | 100.00% | 19,249,458 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.54% | 1.76% | 871,974 | 348,808 | 66.67% | 37,599,519 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.57% | 0.08% | 322,882 | 322,882 | 100.00% | 13,922,022 | Jun 30, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 0.56% | 0.02% | 320,467 | 320,467 | 100.00% | 13,818,537 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.19% | 0.03% | 678,234 | 316,100 | 87.29% | 29,245,450 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.56% | 0.05% | 320,531 | 277,318 | 641.75% | 13,821,297 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 0.44% | 0.67% | 249,311 | 249,311 | 100.00% | 10,750,290 | Jun 30, 2024 |
| NORGES BANK | 0.43% | 0.00% | 242,734 | 242,734 | 100.00% | 10,466,690 | Jun 30, 2024 |
| BLACKROCK INC. | 8.55% | 0.00% | 4,859,002 | 200,907 | 4.31% | 209,520,165 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.31% | 0.04% | 174,870 | 174,870 | 100.00% | 7,540,394 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.56% | 0.00% | 317,941 | 161,835 | 103.67% | 13,709,616 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 0.24% | 0.24% | 136,838 | 136,838 | 100.00% | 5,900,455 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.23% | 0.01% | 130,411 | 130,411 | 100.00% | 5,623,322 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.20% | 0.05% | 113,378 | 113,378 | 100.00% | 4,888,859 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.27% | 0.10% | 155,076 | 94,387 | 155.53% | 6,686,877 | Jun 30, 2024 |
As of Jun 30 2024, Agios Pharmaceuticals's largest institutional buyer is BVF INC/IL. The company purchased 1.19M stocks of AGIO, valued at $51.32M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STATE STREET CORP | 3.72% | 0.00% | 2,114,949 | -1,023,248 | -32.61% | 91,196,601,000 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | - | - | - | -928,596 | -100.00% | - | Jun 30, 2024 |
| ARMISTICE CAPITAL, LLC | 3.66% | 1.13% | 2,079,151 | -884,849 | -29.85% | 89,652,991 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.84% | 1.36% | 1,044,261 | -720,244 | -40.82% | 45,028,534 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 3.13% | 0.01% | 1,776,145 | -696,545 | -28.17% | 76,587,373 | Jun 30, 2024 |
| MORGAN STANLEY | 1.05% | 0.00% | 596,675 | -583,651 | -49.45% | 25,728,626 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 0.74% | 0.02% | 422,044 | -583,582 | -58.03% | 18,198,537 | Jun 30, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 1.79% | 0.52% | 1,019,357 | -499,806 | -32.90% | 43,954,674 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | - | - | - | -400,000 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 3.87% | 0.02% | 2,196,085 | -382,473 | -14.83% | 94,697,055 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | - | - | - | -325,000 | -100.00% | - | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.24% | 0.01% | 134,980 | -319,821 | -70.32% | 5,820,338 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.20% | 0.02% | 115,000 | -292,500 | -71.78% | 4,958,800 | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | - | - | - | -288,580 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 3.05% | 0.09% | 1,729,729 | -229,928 | -11.73% | 74,586,000 | Jun 30, 2024 |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 1.60% | 0.10% | 911,175 | -197,438 | -17.81% | 39,290,000 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.14% | 0.01% | 76,853 | -144,356 | -65.26% | 3,313,901 | Jun 30, 2024 |
| BELLEVUE GROUP AG | 6.83% | 2.72% | 3,879,548 | -126,452 | -3.16% | 167,286,110 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.04% | 0.00% | 19,910 | -126,417 | -86.39% | 858,519 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -122,282 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Agios Pharmaceuticals's biggest institutional seller is STATE STREET CORP. The company sold -1.02M shares of AGIO, valued at $91.20B.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | 2.10% | 1.44% | 1,190,107 | 1,190,107 | 100.00% | 51,317,414 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.82% | 0.13% | 464,121 | 464,121 | 100.00% | 20,012,896 | Jun 30, 2024 |
| LOOMIS SAYLES & CO L P | 0.79% | 0.03% | 448,863 | 448,863 | 100.00% | 19,355,000 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.79% | 2.58% | 446,416 | 446,416 | 100.00% | 19,249,458 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.57% | 0.08% | 322,882 | 322,882 | 100.00% | 13,922,022 | Jun 30, 2024 |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 0.56% | 0.02% | 320,467 | 320,467 | 100.00% | 13,818,537 | Jun 30, 2024 |
| CENTERBOOK PARTNERS LP | 0.44% | 0.67% | 249,311 | 249,311 | 100.00% | 10,750,290 | Jun 30, 2024 |
| NORGES BANK | 0.43% | 0.00% | 242,734 | 242,734 | 100.00% | 10,466,690 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.31% | 0.04% | 174,870 | 174,870 | 100.00% | 7,540,394 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 0.24% | 0.24% | 136,838 | 136,838 | 100.00% | 5,900,455 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.20% | 0.05% | 113,378 | 113,378 | 100.00% | 4,888,859 | Jun 30, 2024 |
| EAM INVESTORS, LLC | 0.13% | 0.52% | 74,142 | 74,142 | 100.00% | 3,197,003 | Jun 30, 2024 |
| MOORE CAPITAL MANAGEMENT, LP | 0.11% | 0.04% | 60,000 | 60,000 | 100.00% | 2,587,200 | Jun 30, 2024 |
| EDGESTREAM PARTNERS, L.P. | 0.07% | 0.09% | 42,076 | 42,076 | 100.00% | 1,814,317 | Jun 30, 2024 |
| SEVEN EIGHT CAPITAL, LP | 0.07% | 0.18% | 39,262 | 39,262 | 100.00% | 1,692,977 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.06% | 0.00% | 36,140 | 36,140 | 100.00% | 1,559,775 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.01% | 30,406 | 30,406 | 100.00% | 1,311,107 | Jun 30, 2024 |
| NOMURA HOLDINGS INC | 0.05% | 0.00% | 29,000 | 29,000 | 100.00% | 1,250,480 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.05% | 0.00% | 27,000 | 27,000 | 100.00% | 1,164,240 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.05% | 0.06% | 25,945 | 25,945 | 100.00% | 1,118,748 | Jun 30, 2024 |
| SEI INVESTMENTS CO | 0.04% | 0.00% | 23,378 | 23,378 | 100.00% | 1,008,071,000 | Jun 30, 2024 |
| GTS SECURITIES LLC | 0.04% | 0.00% | 22,800 | 22,800 | 100.00% | 983,136 | Jun 30, 2024 |
| SCIENTECH RESEARCH LLC | 0.03% | 0.16% | 17,592 | 17,592 | 100.00% | 758,567 | Jun 30, 2024 |
| NOMURA HOLDINGS INC | 0.02% | 0.00% | 12,106 | 12,106 | 100.00% | 522,011 | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | 0.02% | 0.01% | 8,800 | 8,800 | 100.00% | 379,456 | Jun 30, 2024 |
| ATRIA INVESTMENTS, INC | 0.01% | 0.00% | 7,210 | 7,210 | 100.00% | 310,895 | Jun 30, 2024 |
| GALLAGHER FIDUCIARY ADVISORS, LLC | 0.01% | 0.07% | 6,940 | 6,940 | 100.00% | 299,253 | Jun 30, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | 0.01% | 0.06% | 6,818 | 6,818 | 100.00% | 293,992 | Jun 30, 2024 |
| COMMERCE BANK | 0.01% | 0.00% | 6,239 | 6,239 | 100.00% | 269,024 | Jun 30, 2024 |
| NORTHCAPE WEALTH MANAGEMENT, LLC | 0.01% | 0.09% | 5,670 | 5,670 | 100.00% | 244,490 | Jun 30, 2024 |
| NORTH STAR ASSET MANAGEMENT INC | 0.01% | 0.01% | 5,000 | 5,000 | 100.00% | 215,600 | Jun 30, 2024 |
| BRIDGEFRONT CAPITAL, LLC | 0.01% | 0.09% | 4,965 | 4,965 | 100.00% | 214,091 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.01% | 0.01% | 4,960 | 4,960 | 100.00% | 214,000 | Jun 30, 2024 |
| KBC GROUP NV | 0.00% | 0.00% | 2,004 | 2,004 | 100.00% | 86,000 | Jun 30, 2024 |
| STATE OF WYOMING | 0.00% | 0.01% | 1,136 | 1,136 | 100.00% | 48,984 | Jun 30, 2024 |
| STRS OHIO | 0.00% | 0.00% | 1,100 | 1,100 | 100.00% | 47,432,000 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.00% | 0.00% | 864 | 864 | 100.00% | 37,000 | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | 0.00% | 0.00% | 492 | 492 | 100.00% | 21,215 | Jun 30, 2024 |
| SUNBELT SECURITIES, INC. | 0.00% | 0.00% | 225 | 225 | 100.00% | 9,702 | Jun 30, 2024 |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 0.00% | 0.00% | 200 | 200 | 100.00% | 8,624 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 86 | 86 | 100.00% | 3,750 | Jun 30, 2024 |
| MATHER GROUP, LLC. | 0.00% | - | 55 | 55 | 100.00% | 1,608 | Jun 30, 2024 |
| STEPHENS CONSULTING, LLC | 0.00% | 0.00% | 55 | 55 | 100.00% | 2,372 | Jun 30, 2024 |
| TWIN TREE MANAGEMENT, LP | 0.00% | - | 52 | 52 | 100.00% | 2,242 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | 0.00% | 17 | 17 | 100.00% | 733 | Jun 30, 2024 |
| CVA FAMILY OFFICE, LLC | - | 0.00% | 15 | 15 | 100.00% | 647 | Jun 30, 2024 |
| COVESTOR LTD | - | 0.00% | 12 | 12 | 100.00% | 1,000 | Jun 30, 2024 |
Agios Pharmaceuticals's largest new institutional shareholder by number of shares is BVF INC/IL, purchased 1.19M shares, valued at $51.32M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | - | - | - | -928,596 | -100.00% | - | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | - | - | - | -400,000 | -100.00% | - | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | - | - | - | -325,000 | -100.00% | - | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | - | - | - | -288,580 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -122,282 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -101,612 | -100.00% | - | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -59,902 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -35,734 | -100.00% | - | Jun 30, 2024 |
| NEBULA RESEARCH & DEVELOPMENT LLC | - | - | - | -34,855 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -30,853 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -27,375 | -100.00% | - | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | - | - | - | -25,000 | -100.00% | - | Jun 30, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | - | - | - | -24,000 | -100.00% | - | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | - | - | - | -17,658 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -15,056 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -14,714 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -10,900 | -100.00% | - | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -9,787 | -100.00% | - | Jun 30, 2024 |
| ROYCE & ASSOCIATES LP | - | - | - | -7,338 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,956 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -2,924 | -100.00% | - | Jun 30, 2024 |
| NORTH STAR INVESTMENT MANAGEMENT CORP. | - | - | - | -125 | -100.00% | - | Jun 30, 2024 |
| SYSTM WEALTH SOLUTIONS LLC | - | - | - | -35 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -11 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL SECURITIES, INC. | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
Agios Pharmaceuticals's largest sold out institutional shareholder by shares sold is T. ROWE PRICE INVESTMENT MANAGEMENT, INC., sold -0.93M shares, valued at -, as of undefined.
Agios Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| SPARROW FUNDS | 2.65% | 9,455 | - | - | Feb 29, 2024 |
| Manager Directed Portfolios | 0.40% | 66,182 | - | - | Jan 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.22% | 54,568 | - | - | Dec 31, 2023 |
| JP MORGAN MUTUAL FUND INVESTMENT TRUST | 0.22% | 819,685 | - | - | Dec 31, 2023 |
| Tema ETF Trust | 0.21% | 9,581 | 143 | 1.52% | Feb 29, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.21% | 712,121 | 360,403 | 102.47% | Mar 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.20% | 407,505 | - | - | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.18% | 1,764,743 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.16% | 416,093 | - | - | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.14% | 123,156 | - | - | Mar 31, 2024 |
| MERIDIAN FUND INC | 0.14% | 329,506 | - | - | Mar 28, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.14% | 63,808 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.12% | 423,233 | -600 | -0.14% | Mar 31, 2024 |
| NEW PERSPECTIVE FUND | 0.10% | 3,166,698 | - | - | Mar 31, 2024 |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. | 0.10% | 33,900 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.10% | 485,137 | -90,050 | -15.66% | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.09% | 290,281 | - | - | Mar 31, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.07% | 8,740 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 37,588 | - | - | Mar 31, 2024 |
| WANGER ADVISORS TRUST | 0.06% | 33,338 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.06% | 682,914 | - | - | Jan 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.05% | 27,890 | - | - | Mar 31, 2024 |
| TAX-MANAGED GROWTH PORTFOLIO | 0.05% | 20,092 | - | - | Mar 31, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.05% | 2,534,113 | - | - | Jan 31, 2024 |
| BlackRock Health Sciences Trust | 0.04% | 10,515 | - | - | Mar 31, 2024 |
| PRUDENTIAL JENNISON SMALL CO FUND, INC. | 0.03% | 149,360 | - | - | Mar 28, 2024 |
| Northern Lights Variable Trust | 0.03% | 31,140 | - | - | Mar 31, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.03% | 93,303 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.03% | 863,383 | - | - | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.03% | 250,000 | - | - | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS V | 0.03% | 1,623,319 | -6,594 | -0.40% | Feb 29, 2024 |
| COLUMBIA ACORN TRUST | 0.03% | 83,573 | - | - | Mar 31, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.02% | 14,961 | - | - | Feb 29, 2024 |
| Humankind Benefit Corp | 0.02% | 505 | 73 | 16.90% | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.02% | 60,000 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.02% | 36,365 | 19,000 | 109.42% | Mar 31, 2024 |
| TOCQUEVILLE TRUST | 0.02% | 3,000 | - | - | Jan 31, 2024 |
| T. Rowe Price Tax-Efficient Funds, Inc. | 0.02% | 2,000 | - | - | Feb 29, 2024 |
| Vericimetry Funds | 0.02% | 1,660 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.02% | 198,600 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 98,675 | -1,919 | -1.91% | Mar 31, 2024 |
| ROYCE MICRO-CAP TRUST, INC. | 0.02% | 7,338 | - | - | Mar 31, 2024 |
| ACAP Strategic Fund | 0.01% | 205,312 | - | - | Mar 31, 2024 |
| LEGG MASON PARTNERS INVESTMENT TRUST | 0.01% | 699,374 | - | - | Mar 28, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 8,132 | -264 | -3.14% | Mar 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.01% | 363,194 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.01% | 2,250 | - | - | Mar 28, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.01% | 45,228 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 4,915,451 | -785,390 | -13.78% | Mar 31, 2024 |
| Calvert Responsible Index Series, Inc. | 0.01% | 18,168 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.01% | 88,200 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 14,036 | 2,213 | 18.72% | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,876 | - | - | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.01% | 43,942 | -2,593 | -5.57% | Mar 31, 2020 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 24,328 | 372 | 1.55% | Feb 29, 2024 |
| Nushares ETF Trust | 0.01% | 51,899 | - | - | Jan 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 360,000 | - | - | Feb 29, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 58,576 | - | - | Jan 31, 2024 |
| LEGG MASON PARTNERS VARIABLE EQUITY TRUST | 0.01% | 20,831 | - | - | Dec 29, 2023 |
| AMG Funds IV | 0.00% | 15,044 | 6,146 | 69.07% | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 175,193 | -604 | -0.34% | Jan 31, 2024 |
| John Hancock Exchange-Traded Fund Trust | 0.00% | 24,761 | - | - | Jan 31, 2024 |
| ETF Managers Trust | 0.00% | 28,765 | -1,337 | -4.44% | Dec 31, 2023 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 182,642 | - | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 314,314 | - | - | Jan 31, 2024 |
| ALPS ETF Trust | 0.00% | 40,804 | 1,430 | 3.63% | Feb 29, 2024 |
| AMG FUNDS | 0.00% | 93,104 | 93,104 | - | Mar 28, 2024 |
| Brown Advisory Funds | 0.00% | 116,559 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS VARIABLE SERIES II | 0.00% | 7,142 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 14,943 | - | - | Mar 31, 2024 |
| TARGET PORTFOLIO TRUST | 0.00% | 54,300 | - | - | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 535,769 | 11,972 | 2.29% | Feb 29, 2024 |
| DELAWARE VIP TRUST | 0.00% | 8,469 | - | - | Mar 28, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 393,672 | - | - | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 65,620 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 5,519 | - | - | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 100,000 | - | - | Feb 29, 2024 |
| Federated Hermes Adviser Series | 0.00% | 12,228 | 1,219 | 11.07% | Mar 31, 2024 |
| CAPITAL GROUP PRIVATE CLIENT SERVICES FUNDS | 0.00% | 12,200 | - | - | Jan 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.00% | 128,700 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 798,791 | 52,462 | 7.03% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 1,676,614 | 303,252 | 22.08% | Jan 31, 2024 |
| HARBOR FUNDS | 0.00% | 35,258 | - | - | Jan 31, 2024 |
| AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST) | 0.00% | 328,860 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 28,000 | - | - | Mar 31, 2024 |
| SEI Catholic Values Trust | 0.00% | 3,322 | - | - | Feb 29, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 17,946 | -898 | -4.77% | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 33,867 | -2,705 | -7.40% | Mar 31, 2024 |
| PFM Multi-Manager Series Trust | 0.00% | 900 | - | - | Dec 31, 2023 |
| Amplify ETF Trust | 0.00% | 28,754 | 28,754 | - | Mar 31, 2024 |
| ProFunds | 0.00% | 11,661 | 2,594 | 28.61% | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 147,367 | 42,444 | 40.45% | Jan 31, 2024 |
| Federated Hermes Equity Funds | 0.00% | 17,970 | - | - | Jan 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 21,734 | - | - | Mar 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 3,925 | - | - | Mar 28, 2024 |
| Federated Hermes MDT Series | 0.00% | 2,247 | - | - | Jan 31, 2024 |
| BlackRock ETF Trust | 0.00% | 799 | - | - | Jan 31, 2024 |
| Ivy Variable Insurance Portfolios | 0.00% | 19,504 | - | - | Mar 28, 2024 |
| VANGUARD WORLD FUND | 0.00% | 200,307 | 2,768 | 1.40% | Feb 29, 2024 |
| JPMORGAN TRUST II | 0.00% | 802,464 | - | - | Feb 29, 2024 |
Agios Pharmaceuticals's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 9.46K shares, compromising 2.65% of its total assets.
Agios Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 208 | 4.00% |
| 31 Mar, 24 | 200 | 11.73% |
| 31 Dec, 23 | 179 | 15.48% |
| 30 Sep, 23 | 155 | -4.91% |
| 30 Jun, 23 | 163 | -6.32% |
| 31 Mar, 23 | 174 | 2.35% |
| 31 Dec, 22 | 170 | -2.30% |
| 30 Sep, 22 | 174 | 9.43% |
| 30 Jun, 22 | 159 | -3.05% |
| 31 Mar, 22 | 164 | -1.20% |
| 31 Dec, 21 | 166 | -3.49% |
| 30 Sep, 21 | 172 | -13.13% |
| 30 Jun, 21 | 198 | 4.76% |
| 31 Mar, 21 | 189 | -13.30% |
| 31 Dec, 20 | 218 | - |
| 30 Sep, 20 | 218 | -3.54% |
| 30 Jun, 20 | 226 | 5.12% |
| 31 Mar, 20 | 215 | -0.92% |
| 31 Dec, 19 | 217 | 8.50% |
| 30 Sep, 19 | 200 | 0.50% |
| 30 Jun, 19 | 199 | -8.29% |
| 31 Mar, 19 | 217 | 3.83% |
| 31 Dec, 18 | 209 | -5.00% |
| 30 Sep, 18 | 220 | -5.98% |
| 30 Jun, 18 | 234 | 9.86% |
| 31 Mar, 18 | 213 | 14.52% |
| 31 Dec, 17 | 186 | 0.54% |
| 30 Sep, 17 | 185 | 1.65% |
| 30 Jun, 17 | 182 | 8.98% |
| 31 Mar, 17 | 167 | -2.91% |
| 31 Dec, 16 | 172 | -2.27% |
| 30 Sep, 16 | 176 | 7.98% |
| 30 Jun, 16 | 163 | -2.98% |
| 31 Mar, 16 | 168 | 7.69% |
| 31 Dec, 15 | 156 | -1.89% |
| 30 Sep, 15 | 159 | -5.92% |
| 30 Jun, 15 | 169 | 5.63% |
| 31 Mar, 15 | 160 | 2.56% |
| 31 Dec, 14 | 156 | 24.80% |
| 30 Sep, 14 | 125 | 20.19% |
| 30 Jun, 14 | 104 | 40.54% |
| 31 Mar, 14 | 74 | 12.12% |
| 31 Dec, 13 | 66 | -8.33% |
| 30 Sep, 13 | 72 | - |
As of 30 Jun 24, 208 institutions are holding Agios Pharmaceuticals's shares, representing an increase of 4.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 54,694,845 | -8.00% |
| 31 Mar, 24 | 59,453,348 | 2.90% |
| 31 Dec, 23 | 57,776,522 | 1.07% |
| 30 Sep, 23 | 57,163,101 | -0.88% |
| 30 Jun, 23 | 57,672,069 | 0.62% |
| 31 Mar, 23 | 57,314,066 | -0.86% |
| 31 Dec, 22 | 57,809,833 | 2.73% |
| 30 Sep, 22 | 56,273,415 | -1.77% |
| 30 Jun, 22 | 57,289,983 | -1.68% |
| 31 Mar, 22 | 58,266,916 | 1.10% |
| 31 Dec, 21 | 57,632,293 | -3.56% |
| 30 Sep, 21 | 59,758,443 | -7.85% |
| 30 Jun, 21 | 64,850,388 | 1.01% |
| 31 Mar, 21 | 64,201,491 | 0.42% |
| 31 Dec, 20 | 63,934,598 | -1.42% |
| 30 Sep, 20 | 64,855,870 | -2.57% |
| 30 Jun, 20 | 66,567,705 | -2.62% |
| 31 Mar, 20 | 68,357,193 | 0.57% |
| 31 Dec, 19 | 67,968,304 | 11.28% |
| 30 Sep, 19 | 61,079,425 | 1.84% |
| 30 Jun, 19 | 59,974,771 | 0.70% |
| 31 Mar, 19 | 59,559,945 | 3.58% |
| 31 Dec, 18 | 57,502,726 | 3.22% |
| 30 Sep, 18 | 55,710,345 | 2.24% |
| 30 Jun, 18 | 54,488,882 | -0.73% |
| 31 Mar, 18 | 54,892,162 | 16.72% |
| 31 Dec, 17 | 47,030,448 | 2.02% |
| 30 Sep, 17 | 46,101,449 | -0.14% |
| 30 Jun, 17 | 46,168,028 | 12.58% |
| 31 Mar, 17 | 41,010,147 | 5.00% |
| 31 Dec, 16 | 39,058,578 | 3.16% |
| 30 Sep, 16 | 37,863,604 | 5.94% |
| 30 Jun, 16 | 35,740,111 | 5.80% |
| 31 Mar, 16 | 33,780,713 | 2.33% |
| 31 Dec, 15 | 33,012,593 | -18.93% |
| 30 Sep, 15 | 40,722,775 | 35.18% |
| 30 Jun, 15 | 30,124,657 | 7.69% |
| 31 Mar, 15 | 27,973,141 | 1.02% |
| 31 Dec, 14 | 27,690,442 | 13.07% |
| 30 Sep, 14 | 24,490,686 | 3.77% |
| 30 Jun, 14 | 23,601,758 | 14.87% |
| 31 Mar, 14 | 20,545,963 | 11.47% |
| 31 Dec, 13 | 18,431,648 | 112.64% |
| 30 Sep, 13 | 8,668,124 | - |
Agios Pharmaceuticals (AGIO) has 54.69M shares outstanding as of 30 Jun 24, down -8.00% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 96.29% | 0.87% |
| 31 Mar, 24 | 105.44% | 0.98% |
| 31 Dec, 23 | 103.82% | 0.99% |
| 30 Sep, 23 | 102.44% | 0.95% |
| 30 Jun, 23 | 103.91% | 0.96% |
| 31 Mar, 23 | 103.99% | 0.93% |
| 31 Dec, 22 | 105.51% | 1.00% |
| 30 Sep, 22 | 102.61% | 0.94% |
| 30 Jun, 22 | 104.54% | 0.91% |
| 31 Mar, 22 | 106.97% | 1.18% |
| 31 Dec, 21 | 95.34% | 0.87% |
| 30 Sep, 21 | 104.75% | 0.93% |
| 30 Jun, 21 | 106.20% | 1.25% |
| 31 Mar, 21 | 92.32% | 1.08% |
| 31 Dec, 20 | 92.30% | 1.05% |
| 30 Sep, 20 | 93.80% | 1.01% |
| 30 Jun, 20 | 96.53% | 0.97% |
| 31 Mar, 20 | 99.63% | 0.88% |
| 31 Dec, 19 | 106.28% | 0.99% |
| 30 Sep, 19 | 103.87% | 1.00% |
| 30 Jun, 19 | 102.13% | 0.98% |
| 31 Mar, 19 | 101.89% | 1.04% |
| 31 Dec, 18 | 98.82% | 1.07% |
| 30 Sep, 18 | 96.00% | 1.08% |
| 30 Jun, 18 | 94.40% | 0.97% |
| 31 Mar, 18 | 98.56% | 0.97% |
| 31 Dec, 17 | 100.95% | 1.12% |
| 30 Sep, 17 | 95.13% | 0.98% |
| 30 Jun, 17 | 98.76% | 1.05% |
| 31 Mar, 17 | 97.00% | 0.97% |
| 31 Dec, 16 | 99.83% | 1.03% |
| 30 Sep, 16 | 98.22% | 1.11% |
| 30 Jun, 16 | 94.16% | 1.18% |
| 31 Mar, 16 | 89.22% | 1.16% |
| 31 Dec, 15 | 87.66% | 0.74% |
| 30 Sep, 15 | 108.57% | 1.67% |
| 30 Jun, 15 | 80.70% | 1.43% |
| 31 Mar, 15 | 75.17% | 1.11% |
| 31 Dec, 14 | 82.25% | 1.63% |
| 30 Sep, 14 | 71.00% | 1.44% |
| 30 Jun, 14 | 70.24% | 1.64% |
| 31 Mar, 14 | 65.44% | 1.86% |
| 31 Dec, 13 | 59.37% | 4.03% |
| 30 Sep, 13 | 38.38% | - |
As of 30 Jun 24, Agios Pharmaceuticals is held by 96.29% institutional shareholders, representing a 0.87% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 97 | -5.83% |
| 31 Mar, 24 | 103 | 9.57% |
| 31 Dec, 23 | 94 | 40.30% |
| 30 Sep, 23 | 67 | -17.28% |
| 30 Jun, 23 | 81 | 9.46% |
| 31 Mar, 23 | 74 | -18.68% |
| 31 Dec, 22 | 91 | 1.11% |
| 30 Sep, 22 | 90 | 21.62% |
| 30 Jun, 22 | 74 | 19.35% |
| 31 Mar, 22 | 62 | -13.89% |
| 31 Dec, 21 | 72 | 14.29% |
| 30 Sep, 21 | 63 | -30.00% |
| 30 Jun, 21 | 90 | 8.43% |
| 31 Mar, 21 | 83 | -17.00% |
| 31 Dec, 20 | 100 | -11.50% |
| 30 Sep, 20 | 113 | -1.74% |
| 30 Jun, 20 | 115 | 27.78% |
| 31 Mar, 20 | 90 | -34.31% |
| 31 Dec, 19 | 137 | 31.73% |
| 30 Sep, 19 | 104 | 8.33% |
| 30 Jun, 19 | 96 | -22.58% |
| 31 Mar, 19 | 124 | 20.39% |
| 31 Dec, 18 | 103 | 8.42% |
| 30 Sep, 18 | 95 | -20.17% |
| 30 Jun, 18 | 119 | -10.53% |
| 31 Mar, 18 | 133 | 41.49% |
| 31 Dec, 17 | 94 | 8.05% |
| 30 Sep, 17 | 87 | -23.68% |
| 30 Jun, 17 | 114 | 32.56% |
| 31 Mar, 17 | 86 | 2.38% |
| 31 Dec, 16 | 84 | -20.75% |
| 30 Sep, 16 | 106 | 7.07% |
| 30 Jun, 16 | 99 | 6.45% |
| 31 Mar, 16 | 93 | 22.37% |
| 31 Dec, 15 | 76 | -12.64% |
| 30 Sep, 15 | 87 | -13.86% |
| 30 Jun, 15 | 101 | 6.32% |
| 31 Mar, 15 | 95 | -4.04% |
| 31 Dec, 14 | 99 | 39.44% |
| 30 Sep, 14 | 71 | -2.74% |
| 30 Jun, 14 | 73 | 58.70% |
| 31 Mar, 14 | 46 | 9.52% |
| 31 Dec, 13 | 42 | -41.67% |
| 30 Sep, 13 | 72 | - |
97 institutional shareholders have increased their position in AGIO stock as of 30 Jun 24 compared to 103 in the previous quarter (a -5.83% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 75 | 33.93% |
| 31 Mar, 24 | 56 | 12.00% |
| 31 Dec, 23 | 50 | 6.38% |
| 30 Sep, 23 | 47 | 6.82% |
| 30 Jun, 23 | 44 | -30.16% |
| 31 Mar, 23 | 63 | 28.57% |
| 31 Dec, 22 | 49 | - |
| 30 Sep, 22 | 49 | 2.08% |
| 30 Jun, 22 | 48 | -14.29% |
| 31 Mar, 22 | 56 | -5.08% |
| 31 Dec, 21 | 59 | -13.24% |
| 30 Sep, 21 | 68 | 4.62% |
| 30 Jun, 21 | 65 | -5.80% |
| 31 Mar, 21 | 69 | -2.82% |
| 31 Dec, 20 | 71 | 20.34% |
| 30 Sep, 20 | 59 | - |
| 30 Jun, 20 | 59 | -14.49% |
| 31 Mar, 20 | 69 | 53.33% |
| 31 Dec, 19 | 45 | -15.09% |
| 30 Sep, 19 | 53 | -14.52% |
| 30 Jun, 19 | 62 | 29.17% |
| 31 Mar, 19 | 48 | -17.24% |
| 31 Dec, 18 | 58 | -20.55% |
| 30 Sep, 18 | 73 | 21.67% |
| 30 Jun, 18 | 60 | 39.53% |
| 31 Mar, 18 | 43 | -27.12% |
| 31 Dec, 17 | 59 | 3.51% |
| 30 Sep, 17 | 57 | 62.86% |
| 30 Jun, 17 | 35 | -25.53% |
| 31 Mar, 17 | 47 | -9.62% |
| 31 Dec, 16 | 52 | 52.94% |
| 30 Sep, 16 | 34 | -15.00% |
| 30 Jun, 16 | 40 | -9.09% |
| 31 Mar, 16 | 44 | - |
| 31 Dec, 15 | 44 | -4.35% |
| 30 Sep, 15 | 46 | 9.52% |
| 30 Jun, 15 | 42 | 2.44% |
| 31 Mar, 15 | 41 | 5.13% |
| 31 Dec, 14 | 39 | 18.18% |
| 30 Sep, 14 | 33 | 50.00% |
| 30 Jun, 14 | 22 | 4.76% |
| 31 Mar, 14 | 21 | 23.53% |
| 31 Dec, 13 | 17 | - |
| 30 Sep, 13 | - | - |
75 institutional shareholders have reduced their position in AGIO stock as of 30 Jun 24 compared to 56 in the previous quarter (a 33.93% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 208 | 4.00% | 54,694,845 | -8.00% | 96.29% | 0.87% | 97 | -5.83% | 75 | 33.93% |
| 31 Mar, 24 | 200 | 11.73% | 59,453,348 | 2.90% | 105.44% | 0.98% | 103 | 9.57% | 56 | 12.00% |
| 31 Dec, 23 | 179 | 15.48% | 57,776,522 | 1.07% | 103.82% | 0.99% | 94 | 40.30% | 50 | 6.38% |
| 30 Sep, 23 | 155 | -4.91% | 57,163,101 | -0.88% | 102.44% | 0.95% | 67 | -17.28% | 47 | 6.82% |
| 30 Jun, 23 | 163 | -6.32% | 57,672,069 | 0.62% | 103.91% | 0.96% | 81 | 9.46% | 44 | -30.16% |
| 31 Mar, 23 | 174 | 2.35% | 57,314,066 | -0.86% | 103.99% | 0.93% | 74 | -18.68% | 63 | 28.57% |
| 31 Dec, 22 | 170 | -2.30% | 57,809,833 | 2.73% | 105.51% | 1.00% | 91 | 1.11% | 49 | - |
| 30 Sep, 22 | 174 | 9.43% | 56,273,415 | -1.77% | 102.61% | 0.94% | 90 | 21.62% | 49 | 2.08% |
| 30 Jun, 22 | 159 | -3.05% | 57,289,983 | -1.68% | 104.54% | 0.91% | 74 | 19.35% | 48 | -14.29% |
| 31 Mar, 22 | 164 | -1.20% | 58,266,916 | 1.10% | 106.97% | 1.18% | 62 | -13.89% | 56 | -5.08% |
| 31 Dec, 21 | 166 | -3.49% | 57,632,293 | -3.56% | 95.34% | 0.87% | 72 | 14.29% | 59 | -13.24% |
| 30 Sep, 21 | 172 | -13.13% | 59,758,443 | -7.85% | 104.75% | 0.93% | 63 | -30.00% | 68 | 4.62% |
| 30 Jun, 21 | 198 | 4.76% | 64,850,388 | 1.01% | 106.20% | 1.25% | 90 | 8.43% | 65 | -5.80% |
| 31 Mar, 21 | 189 | -13.30% | 64,201,491 | 0.42% | 92.32% | 1.08% | 83 | -17.00% | 69 | -2.82% |
| 31 Dec, 20 | 218 | - | 63,934,598 | -1.42% | 92.30% | 1.05% | 100 | -11.50% | 71 | 20.34% |
| 30 Sep, 20 | 218 | -3.54% | 64,855,870 | -2.57% | 93.80% | 1.01% | 113 | -1.74% | 59 | - |
| 30 Jun, 20 | 226 | 5.12% | 66,567,705 | -2.62% | 96.53% | 0.97% | 115 | 27.78% | 59 | -14.49% |
| 31 Mar, 20 | 215 | -0.92% | 68,357,193 | 0.57% | 99.63% | 0.88% | 90 | -34.31% | 69 | 53.33% |
| 31 Dec, 19 | 217 | 8.50% | 67,968,304 | 11.28% | 106.28% | 0.99% | 137 | 31.73% | 45 | -15.09% |
| 30 Sep, 19 | 200 | 0.50% | 61,079,425 | 1.84% | 103.87% | 1.00% | 104 | 8.33% | 53 | -14.52% |
| 30 Jun, 19 | 199 | -8.29% | 59,974,771 | 0.70% | 102.13% | 0.98% | 96 | -22.58% | 62 | 29.17% |
| 31 Mar, 19 | 217 | 3.83% | 59,559,945 | 3.58% | 101.89% | 1.04% | 124 | 20.39% | 48 | -17.24% |
| 31 Dec, 18 | 209 | -5.00% | 57,502,726 | 3.22% | 98.82% | 1.07% | 103 | 8.42% | 58 | -20.55% |
| 30 Sep, 18 | 220 | -5.98% | 55,710,345 | 2.24% | 96.00% | 1.08% | 95 | -20.17% | 73 | 21.67% |
| 30 Jun, 18 | 234 | 9.86% | 54,488,882 | -0.73% | 94.40% | 0.97% | 119 | -10.53% | 60 | 39.53% |
| 31 Mar, 18 | 213 | 14.52% | 54,892,162 | 16.72% | 98.56% | 0.97% | 133 | 41.49% | 43 | -27.12% |
| 31 Dec, 17 | 186 | 0.54% | 47,030,448 | 2.02% | 100.95% | 1.12% | 94 | 8.05% | 59 | 3.51% |
| 30 Sep, 17 | 185 | 1.65% | 46,101,449 | -0.14% | 95.13% | 0.98% | 87 | -23.68% | 57 | 62.86% |
| 30 Jun, 17 | 182 | 8.98% | 46,168,028 | 12.58% | 98.76% | 1.05% | 114 | 32.56% | 35 | -25.53% |
| 31 Mar, 17 | 167 | -2.91% | 41,010,147 | 5.00% | 97.00% | 0.97% | 86 | 2.38% | 47 | -9.62% |
| 31 Dec, 16 | 172 | -2.27% | 39,058,578 | 3.16% | 99.83% | 1.03% | 84 | -20.75% | 52 | 52.94% |
| 30 Sep, 16 | 176 | 7.98% | 37,863,604 | 5.94% | 98.22% | 1.11% | 106 | 7.07% | 34 | -15.00% |
| 30 Jun, 16 | 163 | -2.98% | 35,740,111 | 5.80% | 94.16% | 1.18% | 99 | 6.45% | 40 | -9.09% |
| 31 Mar, 16 | 168 | 7.69% | 33,780,713 | 2.33% | 89.22% | 1.16% | 93 | 22.37% | 44 | - |
| 31 Dec, 15 | 156 | -1.89% | 33,012,593 | -18.93% | 87.66% | 0.74% | 76 | -12.64% | 44 | -4.35% |
| 30 Sep, 15 | 159 | -5.92% | 40,722,775 | 35.18% | 108.57% | 1.67% | 87 | -13.86% | 46 | 9.52% |
| 30 Jun, 15 | 169 | 5.63% | 30,124,657 | 7.69% | 80.70% | 1.43% | 101 | 6.32% | 42 | 2.44% |
| 31 Mar, 15 | 160 | 2.56% | 27,973,141 | 1.02% | 75.17% | 1.11% | 95 | -4.04% | 41 | 5.13% |
| 31 Dec, 14 | 156 | 24.80% | 27,690,442 | 13.07% | 82.25% | 1.63% | 99 | 39.44% | 39 | 18.18% |
| 30 Sep, 14 | 125 | 20.19% | 24,490,686 | 3.77% | 71.00% | 1.44% | 71 | -2.74% | 33 | 50.00% |
| 30 Jun, 14 | 104 | 40.54% | 23,601,758 | 14.87% | 70.24% | 1.64% | 73 | 58.70% | 22 | 4.76% |
| 31 Mar, 14 | 74 | 12.12% | 20,545,963 | 11.47% | 65.44% | 1.86% | 46 | 9.52% | 21 | 23.53% |
| 31 Dec, 13 | 66 | -8.33% | 18,431,648 | 112.64% | 59.37% | 4.03% | 42 | -41.67% | 17 | - |
| 30 Sep, 13 | 72 | - | 8,668,124 | - | 38.38% | - | 72 | - | - | - |
Agios Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Agios Pharmaceuticals's stock was made by Ballal Rahul D. on Aug 13 2024, selling 2,302 shares at - per share (valued at -).
Agios Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 4 | 6 | 66.67% |
| Q2 2024 | 29 | 15 | 193.33% |
| Q1 2024 | 37 | 57 | 64.91% |
| Q3 2023 | 7 | 12 | 58.33% |
| Q2 2023 | 30 | 20 | 150.00% |
| Q1 2023 | 27 | 37 | 72.97% |
| Q4 2022 | 4 | 8 | 50.00% |
| Q3 2022 | 9 | - | - |
| Q2 2022 | 22 | 7 | 314.29% |
| Q1 2022 | 29 | 51 | 56.86% |
| Q4 2021 | 2 | 12 | 16.67% |
| Q3 2021 | - | 11 | - |
| Q2 2021 | 32 | 30 | 106.67% |
| Q1 2021 | 24 | 34 | 70.59% |
| Q4 2020 | 2 | 2 | 100.00% |
| Q3 2020 | - | 1 | - |
| Q2 2020 | 27 | 20 | 135.00% |
| Q1 2020 | 24 | 30 | 80.00% |
| Q4 2019 | 5 | 1 | 500.00% |
| Q2 2019 | 23 | 17 | 135.29% |
4 total buy trades, and 6 total sell trades (buy/sell ratio of 0.67%) were made by Agios Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 2 | - |
| Q2 2024 | - | 3 | - |
| Q1 2024 | - | 31 | - |
| Q3 2023 | - | 6 | - |
| Q2 2023 | - | 7 | - |
| Q1 2023 | - | 12 | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | 3 | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | 12 | - |
| Q1 2021 | - | 2 | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | 1 | - |
| Q2 2020 | - | 1 | - |
| Q1 2020 | - | 7 | - |
| Q4 2019 | 3 | 1 | 300.00% |
| Q2 2019 | - | 6 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Agios Pharmaceuticals's stocks.
Agios Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| ANAB | AnaptysBio, Inc. |
| PLRX | Pliant Therapeutics, Inc. |
| NRIX | Nurix Therapeutics, Inc. |
| KYMR | Kymera Therapeutics, Inc. |
| ARVN | Arvinas, Inc. |
| IDYA | IDEAYA Biosciences, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| KALV | KalVista Pharmaceuticals, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| MREO | Mereo BioPharma Group plc |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| MGTX | MeiraGTx Holdings plc |
| STOK | Stoke Therapeutics, Inc. |
| BMRN | BioMarin Pharmaceutical Inc. |
| COGT | Cogent Biosciences, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| RLAY | Relay Therapeutics, Inc. |
| SNDX | Syndax Pharmaceuticals, Inc. |
| KROS | Keros Therapeutics, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| MRSN | Mersana Therapeutics, Inc. |
| FIXX | Q32 Bio Inc. |
AGIO Ownership FAQ
Who Owns Agios Pharmaceuticals?
Agios Pharmaceuticals is owned by institutional shareholders (96.29%), insiders (1.55%), and public (2.16%). The largest institutional shareholder of Agios Pharmaceuticals is FARALLON CAPITAL MANAGEMENT LLC (9.95% of total shares) and the top mutual fund owner is SPARROW FUNDS (2.65% of total shares).
Who are the major institutional shareholders of Agios Pharmaceuticals?
Agios Pharmaceuticals's major institutional shareholders are FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BLACKROCK INC., BELLEVUE GROUP AG, and PRICE T ROWE ASSOCIATES INC /MD/. The top five shareholders own together 39.91% of the company's share outstanding.
How many Agios Pharmaceuticals shareholders are there?
As of Jun 2024, there are 208 institutional shareholders of Agios Pharmaceuticals.
What percentage of Agios Pharmaceuticals is owned by FARALLON CAPITAL MANAGEMENT LLC?
FARALLON CAPITAL MANAGEMENT LLC owns 5.65M shares of Agios Pharmaceuticals, representing 9.95% of the company's total shares outstanding, valued at $243.82M (as of Jun 2024).
What percentage of Agios Pharmaceuticals is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 5.5M shares of Agios Pharmaceuticals (AGIO), compromising 9.68% of the company, valued at $237.02M.
What percentage of Agios Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Agios Pharmaceuticals. The company owns 4.86M of the company's shares outstanding (worth $209.52M).